⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9032257 | 0.83 | — | — | |
| SCHEMBL1313526 | 0.81 | — | — | |
| SCHEMBL1314335 | 0.79 | — | — | |
| SCHEMBL5473399 | 0.78 | — | — | |
| SCHEMBL5252546 | 0.77 | — | — | |
| SCHEMBL5255849 | 0.77 | CA12 (0.43) | — | |
| SCHEMBL6985841 | 0.77 | CA12 (0.43) | — | |
| SCHEMBL28841051 | 0.77 | CA12 (0.43) | — | |
| SCHEMBL209481 | 0.73 | — | — | |
| SCHEMBL846626 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 707 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200155637-A1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2020-05-21 | — | — | US | claimed |
| EP-3640263-A1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | UREKA Sarl (FR) | 2020-04-22 | — | — | EP | claimed |
| EP-3466979-B1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | UREKA SARL (FR) | 2019-11-06 | — | — | EP | claimed |
| US-10414722-B2 | Bioinspired catalysis using oligourea helical foldamers | UREKA SARL (FR) | 2019-09-17 | — | — | US | claimed |
| US-10398750-B2 | Peptide-oligourea chimeric compounds and methods of their use | UREKA SARL (FR) | 2019-09-03 | — | — | US | claimed |
| EP-3466979-A1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | UREKA Sarl (FR) | 2019-04-10 | — | — | EP | claimed |
| EP-3036261-B1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | UREKA SARL (FR) | 2018-11-14 | — | — | EP | claimed |
| WO-2016207726-A1 | BIOINSPIRED CATALYSIS USING OLIGOUREA HELICAL FOLDAMERS | UREKA SARL (FR) | 2016-12-29 | — | — | WO | claimed |
| US-20160368864-A1 | BIOINSPIRED CATALYSIS USING OLIGOUREA HELICAL FOLDAMERS | UREKA SARL (FR) | 2016-12-22 | — | — | US | claimed |
| EP-3036261-A1 | PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE | UREKA Sarl (FR) | 2016-06-29 | — | — | EP | claimed |
| CN-1221424-A | Peptide derivatives | ZENECA LTD (GB) | 1999-06-30 | — | — | CN | claimed |
| EP-0914333-A1 | PEPTIDE DERIVATIVES | ZENECA LIMITED (GB) | 1999-05-12 | — | — | EP | claimed |
| EP-0885227-A1 | PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | Dr. Karl Thomae GmbH (DE) | 1998-12-23 | — | — | EP | claimed |
| EP-0882066-A1 | PEPTIDE DERIVATIVES | ZENECA LIMITED (GB) | 1998-12-09 | — | — | EP | claimed |
| WO-1998025951-A1 | INHIBITORS OF PEPTIDE BINDING TO MHC CLASS II PROTEINS | ZENECA LIMITED (GB) | 1998-06-18 | — | — | WO | claimed |
| WO-1998023644-A1 | PEPTIDE DERIVATIVES | ZENECA LIMITED (GB) | 1998-06-04 | — | — | WO | claimed |
| WO-1998017680-A1 | PEPTIDE ANALOGUES CONTAINING A 7-MEMBERED LACTAM RING | ZENECA LIMITED (GB) | 1998-04-30 | — | — | WO | claimed |
| WO-1997046578-A1 | PEPTIDE DERIVATIVES | ZENECA LIMITED (GB) | 1997-12-11 | — | — | WO | claimed |
| WO-1997032882-A1 | PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | DR. KARL THOMAE GMBH (DE) | 1997-09-12 | — | — | WO | claimed |
| WO-1997031023-A1 | PEPTIDE DERIVATIVES | ZENECA LIMITED (GB) | 1997-08-28 | — | — | WO | claimed |